Tandlægerne i Hørning ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.3% 3.5% 1.6% 1.5% 1.5%  
Credit score (0-100)  66 53 74 75 75  
Credit rating  BBB BBB A A A  
Credit limit (kDKK)  0.0 0.0 5.1 7.2 8.8  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  3,887 3,799 4,737 4,318 4,538  
EBITDA  798 497 1,421 939 816  
EBIT  545 245 1,156 634 512  
Pre-tax profit (PTP)  278.8 7.5 772.7 428.1 258.6  
Net earnings  206.1 5.2 606.1 327.7 211.5  
Pre-tax profit without non-rec. items  279 7.5 773 428 259  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  2,741 2,628 2,871 2,707 2,717  
Shareholders equity total  256 206 757 1,027 1,180  
Interest-bearing liabilities  4,197 3,660 3,250 2,761 2,252  
Balance sheet total (assets)  5,608 5,335 5,664 5,796 5,139  

Net Debt  4,124 3,589 3,122 2,759 2,251  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,887 3,799 4,737 4,318 4,538  
Gross profit growth  0.0% -2.3% 24.7% -8.8% 5.1%  
Employees  8 9 9 9 9  
Employee growth %  0.0% 12.5% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,608 5,335 5,664 5,796 5,139  
Balance sheet change%  0.0% -4.9% 6.2% 2.3% -11.3%  
Added value  797.6 496.8 1,420.8 898.8 816.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  5,144 -504 -161 -609 -434  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  14.0% 6.4% 24.4% 14.7% 11.3%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  9.7% 4.5% 21.0% 11.1% 9.4%  
ROI %  11.9% 5.7% 28.2% 15.2% 13.0%  
ROE %  80.5% 2.2% 125.9% 36.7% 19.2%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  4.6% 3.9% 13.4% 17.7% 23.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  517.1% 722.4% 219.7% 293.9% 275.7%  
Gearing %  1,638.6% 1,776.7% 429.6% 268.8% 190.9%  
Net interest  0 0 0 0 0  
Financing costs %  12.7% 6.0% 11.1% 6.9% 10.1%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.1 0.2 0.4 0.1  
Current Ratio  0.1 0.1 0.2 0.4 0.2  
Cash and cash equivalent  72.7 71.8 128.1 1.9 1.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -1,548.4 -1,939.3 -1,884.8 -1,429.4 -1,595.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  100 55 158 100 91  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  100 55 158 104 91  
EBIT / employee  68 27 128 70 57  
Net earnings / employee  26 1 67 36 23